Recombinant enzyme

Recombinant enzyme Necrostatin-1 price expression and affinity purification of FAAH in Dictyostelium and E. coli FAAH was expressed in Dictyostelium as an N-terminal HIS tag fusion protein. FAAH was found to be predominantly a membrane associated protein and to improve yield of the purified protein, a 0.1% concentration of Triton X-100 was used in lysis VX-680 mw buffer to

solubilise membrane fractions. Cells expressing recombinant HIS-FAAH protein (AX3FAAH) were solubilised in lysis buffer and subjected to Ni-NTA affinity chromatography separation. Purified protein obtained was analyzed by Coomassie staining (Figure 2A) and Western blotting analysis (Figure 2B, C) using anti-HIS antibody (Sigma-Aldrich, Oakville, ON, Canada) and anti-FAAH polyclonal antibody (as described in materials and methods) respectively. Initial attempts to express FAAH as a HIS tag fusion protein in E.coli were not successful, as both N-terminal HIS and C-terminal HIS fusions to FAAH were unstable and only a small amount of the protein was made and this was only found in inclusion bodies. Alternatively, in order to simplify large scale recombinant protein production, FAAH was expressed and purified as a recombinant

maltose binding protein (MBP) fusion protein from E.coli (Figure 2D, E). Recombinant FAAH when expressed as N-terminal MBP fusion protein (MBP-FAAH) in E.coli produced a higher yield of soluble recombinant learn more protein. Recombinant FAAH when produced in either Dictyostelium or E.coli migrated on SDS-polyacrylamide gels, consistent with no significant post-translation modification. Figure 2 (A) Coomassie staining of purified HIS-FAAH recombinant protein from Dictyostelium. Dictyostelium cells AX3FAAH expressing HIS-FAAH were lysed and the recombinant protein was bound to Ni-NTA resin.

Resin bound protein was eluted using lysis buffer containing 200 mM Imidazole and the eluate fractions S1, S2, S3, S4, S5 were resolved on 10% SDS-PAGE and Coomassie stained. (B) Western blotting analysis. Fractions analysed in Figure 2A were analysed by Western blotting using anti-HIS antibody. (C) Western blotting analysis. Fractions analysed in Figure 2A/2B were pooled together (P1) PJ34 HCl and analysed by Western blotting using anti-FAAH polyclonal antibody and the same fraction was used in enzyme kinetic assay. (D) Coomassie staining analysis of purified recombinant MBP-FAAH protein from E.coli. Cells expressing recombinant MBP-FAAH were lysed and the recombinant protein was bound to amylose resin. Resin bound recombinant protein was eluted using lysis buffer containing 15 mM maltose and the eluate fractions S6, S7, S8, S9, S10 were resolved on 10% SDS-PAGE and Coomassie stained. (E) Coomassie staining analysis. Fractions analysed in Figure 2D were pooled together (P2) and analysed by Coomassie staining.

Comments are closed.